|
|
|
|
| LEADER |
01552nam a2200289 4500 |
| 001 |
PPN115614443 |
| 003 |
http://www.sudoc.fr/115614443 |
| 005 |
20181126141900.0 |
| 010 |
|
|
|a 92-808-1112-6
|b b.
|
| 035 |
|
|
|a (OCoLC)59280336
|
| 100 |
|
|
|a 20070621d2005 u f0engy0103 ba
|
| 101 |
0 |
|
|a eng
|
| 102 |
|
|
|a JP
|
| 105 |
|
|
|a y s 0|1|y
|
| 106 |
|
|
|a r
|
| 200 |
0 |
|
|a Regulating bioprospecting
|b Texte imprimé
|e institutions for drug research, access and benefit-sharing
|f Padmashree Gehl Sampath
|
| 210 |
|
|
|a Tokyo
|a New York
|a Paris
|c United Nations University Press
|d 2005
|
| 215 |
|
|
|a 1 vol. (XII-274 p.)
|d 24 cm
|
| 300 |
|
|
|a Notes bibliogr. Bibliogr. p. 251-267. Index
|
| 327 |
1 |
|
|a Bioprospecting for drug research: an overview
|a Drug R&D and the structure of the industry
|a International policy dimensions of bioprospecting
|a Transaction costs and their impact on the market for bioprospecting
|a Intellectual property rights on traditional medicinal knowledge: a process oriented perspective
|a The scope of the right to regulate access
|a Conclusions and recommendations
|a Appendix 1: Rights on access and traditional medicinal knowledge
|a Appendix 2: Convention on Biological Diversity
|a Appendix 3: Agreement on Trade-related Aspects of Intellectual Property Rights
|
| 606 |
|
|
|3 PPN027373304
|a Biotechnologie
|2 rameau
|
| 606 |
|
|
|3 PPN027820661
|a Médecine
|x Recherche
|2 rameau
|
| 702 |
|
1 |
|3 PPN115614273
|a Sampath
|b Padmashree Gehl
|4 070
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20070621
|g AFNOR
|
| 979 |
|
|
|a NBU
|
| 930 |
|
|
|5 441095211:309630665
|b 441095211
|j g
|
| 998 |
|
|
|a 500737
|
Nantilus
